Skip to main content

Table 2 Hospitalizations due to ruptured and non-ruptured aortic aneurysm in 2019, 2020 and 2021

From: German nation-wide in-patient treatment of abdominal aortic aneurysm—trends between 2005 and 2019 and impact of the SARS-CoV-2 pandemic

 

2019

2020

2021

Absolute Change

Rel. Change

Absolute Change

Rel. Change

2019–2020

2019–2020

2020–2021

2020–2021

All hospitalizations, n

16,051

14,178

13,273

-1,873

-11.7%

-905

-6.4%

Age, mean (± sd)

73.81 (± 9.04)

73.46 (± 9.14)

73.41 (± 9.23)

-0.35

-0.5%

-0.05

-0.1%

Men, n (%)

13,663 (85.1%)

12,039 (84.9%)

11,150 (84.0%)

-1,624 (-0.2%)

-0.2%

-889 (-0.9%)

-1.1%

In-hospital death, n (%)

1,235 (7.7%)

1,117 (7.9%)

1,129 (8.5%)

-118 (+ 0.2%)

2.4%

 + 12 (+ 0.6%)

8.0%

In-hospital stay, d, median (IQR)

7 (4–11)

6 (4–11)

6 (4–10)

-1

-14.3%

0

0.0%

Comorbidities:

  Primary HT

10,775 (67.1%)

9,782 (69.0%)

9,146 (68.9%)

-993 (+ 1.9%)

2.8%

-636 (-0.1%)

-0.1%

  DLP

6,553 (40.8%)

5,858 (41.3%)

5,711 (43.0%)

-695 (+ 0.5%)

1.2%

-147 (+ 1.7%)

4.1%

  DM-2

2,731 (17.0%)

2,327 (16.4%)

2,279 (17.2%)

-404 (-0.6%)

-3.5%

-48 (+ 0.8%)

4.6%

  CKD

3,861 (24.1%)

3,158 (22.3%)

2,946 (22.2%)

-703 (-1.8%)

-7.4%

-212 (-0.1%)

-0.4%

  CHD

5,060 (31.5%)

4,302 (30.3%)

4,100 (30.9%)

-758 (-1.2%)

-3.7%

-202 (+ 0.5%)

1.8%

  SARS-CoV2-infection

0 (0.0%)

49 (0.3%)

64 (0.5%)

 + 49 (+ 0.3%)

n/a

 + 15 (+ 0.1%)

39.5%

Ruptured aortic abdominal aneurysm

Hospitalizations, n

2,164 (13.5%)

2,080 (14.7%)

1,995 (15.0%)

-84 (+ 1.2%)

8.8%

-85 (+ 0.4%)

2.5%

Age, mean (± sd)

76.10 (± 10.11)

75.53 (± 10.36)

75.29 (± 10.43)

-0.58

-0.8%

-0.24

-0.3%

Men, n (%)

1,743 (80.5%)

1,639 (78.8%)

1,585 (79.4%)

-104 (-1.7%)

-2.2%

-54 (+ 0.7%)

0.8%

Treatment:

  OR, n (%)

788 (36.4%)

728 (35.0%)

695 (34.8%)

-60 (-1.4%)

-3.9%

-33 (-0.2%)

-0.5%

  EVAR, n (%)

455 (21.0%)

440 (21.2%)

461 (23.1%)

-15 (+ 0.1%)

0.6%

 + 21 (+ 2.0%)

9.2%

  combined, n (%)

90 (4.2%)

92 (4.4%)

89 (4.5%)

 + 2 (+ 0.3%)

6.4%

-3 (0.0%)

0.9%

  no intervention, n (%)

831 (38.4%)

820 (39.4%)

750 (37.6%)

-11 (+ 1.0%)

2.7%

-70 (-1.8%)

-4.6%

In-hospital death, n (%)

927 (42.8%)

854 (41.1%)

870 (43.6%)

-73 (-1.8%)

-4.2%

 + 16 (+ 2.6%)

6.2%

In-hospital stay, d, median (IQR)

6 (1–16)

6.5 (1–17)

6 (1–16)

0.5

8.3%

-0.5

-7.7%

Non-ruptured abdominal aortic aneurysm

Hospitalizations, n

13,887 (86.5%)

12,098 (85.3%)

11,278 (85.0%)

-1,789 (-1.2%)

-1.4%

-820 (-0.4%)

-0.4%

Age, mean (± sd)

73.45 (± 8.81)

73.11 (± 8.87)

73.08 (± 8.96)

-0.34

-0.5%

-0.03

0.0%

Men, n (%)

11,920 (85.8%)

10,400 (86.0%)

9,565 (84.8%)

-1,520 (+ 0.1%)

0.2%

-835 (-1.2%)

-1.3%

Treatment:

  OR, n (%)

2,176 (15.7%)

1,984 (16.4%)

1,816 (16.1%)

-192 (+ 0.7%)

4.7%

-168 (-0.3%)

-1.8%

  EVAR, n (%)

6,970 (50.2%)

6,159 (50.9%)

5,660 (50.2%)

-811 (+ 0.7%)

1.4%

-499 (-0.7%)

-1.4%

  combined, n (%)

678 (4.9%)

658 (5.4%)

636 (5.6%)

-29 (+ 0.5%)

9.9%

-22 (+ 0.2%)

3.7%

  no intervention, n (%)

4,054 (29.2%)

3,297 (27.3%)

3,166 (28.1%)

-757 (-1.9%)

-6.6%

-131 (+ 0.8%)

3.0%

In-hospital death, n (%)

308 (2.2%)

263 (2.2%)

259 (2.3%)

-45 (-0.04%)

-2.0%

-4 (+ 0.1%)

5.6%

In-hospital stay, d, median (IQR)

7 (4–10)

6 (4–10)

6 (4–10)

-1

-14.3%

0

0.0%

  1. OR Open repair, EVAR Endovascular aneurysm repair, Sd Standard deviation, IQR Interquartile range, HT Hypertension, DLP Diseases of lipoprotein metabolism, DM-2 Diabetes mellitus type 2, CKD Chronic kidney disease, CHD Chronic heart disease